Format

Send to

Choose Destination
Reprod Sci. 2019 Jul 28:1933719119862050. doi: 10.1177/1933719119862050. [Epub ahead of print]

miR-451a Inhibition Reduces Established Endometriosis Lesions in Mice.

Author information

1
1 Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. Li is now with the Department of Obstetrics and Gynecology, Affiliated to Beijing Chaoyang Hospital, Capital University of Medical Science, Chaoyang District, Beijing, China.

Abstract

Endometriosis is an estrogen-dependent pro-inflammatory disease that affects 6% to 10% of reproductive-age women. Current treatments target sex steroids, and none are disease-specific. MicroRNA treatments have provided promising results for some chronic diseases and cancers. We have previously shown microRNA 451a is increased in endometriosis and that elevation of 451a contributes to the pathophysiology of the disease. Here, we propose inhibition of miR-451a for the treatment of endometriosis in a murine model. Endometriosis was treated using a microRNA 451a inhibitor or a scrambled control microRNA. Treatment with miR-451a inhibitor resulted in reduced endometriosis lesion size (30 vs 13 mm3). There was no difference in the number of visible lesions between the miR-451a treatment and controls. Treatment led to altered expression of several genes including YWHAZ, CAB39, MAPK1, β-catenin, and IL-6. Systemic treatment with a miR-451a inhibitor is a promising therapy for endometriosis that simultaneously affects multiple pathways driving the disease.

KEYWORDS:

endometriosis; miR-451; microRNA; oligonucleotide treatment

PMID:
31354069
DOI:
10.1177/1933719119862050

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center